Transglutaminase Activation in Neurodegenerative Diseases
- 2 July 2009
- journal article
- Published by Taylor & Francis in Future Neurology
- Vol. 4 (4) , 449-467
- https://doi.org/10.2217/fnl.09.17
Abstract
The following review examines the role of calcium in promoting the in vitro and in vivo activation of transglutaminases in neurodegenerative disorders. Diseases such as Alzheimer’s disease, Parkinson’s disease and Huntington’s disease exhibit increased transglutaminase activity and rises in intracellular calcium concentrations, which may be related. The aberrant activation of transglutaminase by calcium is thought to give rise to a variety of pathological moieties in these diseases, and the inhibition has been shown to have therapeutic benefit in animal and cellular models of neurodegeneration. Given the potential clinical relevance of transglutaminase inhibitors, we have also reviewed the recent development of such compounds.Keywords
Funding Information
- National Institutes of Health (2P01 AG14930, R01MH068612)
This publication has 183 references indexed in Scilit:
- Identification of Chemical Inhibitors to Human Tissue Transglutaminase by Screening Existing Drug LibrariesChemistry & Biology, 2008
- Aβ Plaques Lead to Aberrant Regulation of Calcium Homeostasis In Vivo Resulting in Structural and Functional Disruption of Neuronal NetworksNeuron, 2008
- Suppression of Neurodegeneration and Increased Neurotransmission Caused by Expanded Full-Length Huntingtin Accumulating in the CytoplasmPublished by Elsevier ,2008
- Proline cis-trans Isomerization Controls Autoinhibition of a Signaling ProteinMolecular Cell, 2007
- Structure−Activity Relationship Analysis of the Selective Inhibition of Transglutaminase 2 by DihydroisoxazolesJournal of Medicinal Chemistry, 2006
- Importance of Ca2+-Dependent Transamidation Activity in the Protection Afforded by Tissue Transglutaminase against Doxorubicin-Induced ApoptosisBiochemistry, 2006
- Presenilins Form ER Ca2+ Leak Channels, a Function Disrupted by Familial Alzheimer's Disease-Linked MutationsCell, 2006
- Alpha- and beta-secretase activity as a function of age and beta-amyloid in Down syndrome and normal brainNeurobiology of Aging, 2006
- Pathways towards and away from Alzheimer's diseaseNature, 2004
- AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's diseaseNature Genetics, 1998